{
  "docId": "019dd923-622c-750b-8b97-9fb7a842e09f",
  "docSlug": "cddb6c0b289f",
  "documentTitle": "Eurofins Scientific SE (ERF)",
  "authorId": "51_Muddy_Waters",
  "authorName": "Carson C. Block",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2024-06-24 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 11,
  "pageCount": 36,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "research-note",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide contains detailed allegations regarding real estate transactions and cash pooling mechanisms involving Eurofins Finance Luxembourg S.à r.l.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b97-9fb7a842e09f/11",
  "deckHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f#slide-11",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Eurofins, whose BUs are often audited by firms unaffiliated with its consolidated financial auditor Deloitte, routinely has its subsidiaries report Cash & Equivalents balances in inconsistent manners, and often in ways that likely disguise that there is very little actual cash.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b333-7c1976ae42c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.764,
        "x": 0.118,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "Eurofins, whose BUs are often audited by firms unaffiliated with its consolidated financial auditor Deloitte, routinely has its subsidiaries report Cash & Equivalents balances in inconsistent manners, and often in ways that likely disguise that there is very little actual cash.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76c61bd7-dc73-4919-b969-648bd807d4fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.764,
        "x": 0.118,
        "y": 0.565
      },
      "kind": "paragraph",
      "text": "Eurofins physically pools its BUs' cash, primarily in one Luxembourg entity, Eurofins Finance Luxembourg S.à r.l. (“Eurofins Finance”) as we understand. Of the €486.6 million consolidated Cash and Equivalents Eurofins reports as of FY 2022, €137.2 million (or 28.2% of the total) is shown in the 2022 accounts of Eurofins Finance Luxembourg S.à.r.l.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f0fc584-dc86-484f-adc1-ca566e3bba91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.764,
        "x": 0.118,
        "y": 0.825
      },
      "kind": "source-note",
      "text": "Eurofins occupies the first floor, and in a commercial real estate database, Eurofins is listed as a landlord looking to rent out the second floor. The Analytical Bioventures subsidiary that owns the property is Pomona Corporate Real Estate Inc. (“PCRE”), which pursuant to International Assets Finance’s Luxembourg filings, has consistently reported ~$500,000 annual profits since 2017. In 2015 and 2016 when HSBC was a - if not the sole - tenant, PCRE reported ~$500,000 in annual losses.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1209d629-ea5b-4fe0-9bff-cbb07aaf08b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.764,
        "x": 0.118,
        "y": 0.505
      },
      "kind": "title",
      "text": "Eurofins' Deliberate Choice to Obscure Subsidiary Cash and Apparent Cash Confirmation Process Weakness",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47380199-2c6a-42e6-ad0e-6ea7d86e3c80",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.764,
        "x": 0.118,
        "y": 0.25
      },
      "kind": "title",
      "text": "Eurofins' Cash Accounting Seems Designed to Maximize Confusion and Inaccuracy – if Not Outright Overstatement",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "542a1802-c096-4d5c-8588-5f96684623f7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 30,
      "from": 3,
      "beatId": "3d510a0f-6fd9-45d2-879c-09a0eaf3d1a5",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The research note presents various contradictions in Eurofins Scientific's financial reporting and disclosures.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}